OPCH Stock Analysis: Buy, Sell, or Hold?
OPCH - Option Care Health, Inc. Common Stock
$23.70
0.21 (0.89%)
â˛
5d:
-1.02%
30d:
+12.43%
90d:
+10.13%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Get Alerted When OPCH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: OPCH is fairly priced but lacks strong directional signals. At -6.1% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: OPCH is fairly priced but lacks strong directional signals. At -6.1% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$40.52
Based on 7.3% avg growth
INTRINSIC VALUE TODAY
$25.16
5.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OPCH is currently trading at $23.70, which is considered slightly high relative to its 30-day fair value range of $21.84 to $23.91. From a valuation perspective, the stock is trading at a discount (Forward PE: 11.4) compared to its historical average (13.7). Remarkably, the market is currently pricing in an annual earnings decline of 6.1% over the next few years. This pessimistic expectation contrasts with the company's recent 12.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, OPCH is in a downtrend. Immediate support is located at $22.97, while resistance sits at $24.70.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $28.58 (+20.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OPCH is in a downtrend. Immediate support is located at $22.97, while resistance sits at $24.70.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $28.58 (+20.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$21.84 -
$23.91
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
65.2%
All Signals
- NEUTRAL: Mixed technical signals (47/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 20.6% below Wall St target ($28.58)
- WARNING: Composite score 43/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$21.84 -
$23.91
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$22.97
Resistance Level
$24.70
Current Trend
Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.38
Wall Street Target
$28.58
(+20.6%)
Revenue Growth (YoY)
1.9%
Earnings Growth (YoY)
12.9%
Profit Margin
3.7%
Valuation Discount vs History
-6.1% cheaper
PE vs Historical
11.4 vs 13.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.1%
(market-implied from PE analysis)
1-Year Target
$22.25
(-6%)
2-Year Target
$20.90
(-12%)
3-Year Target
$19.62
(-17%)
3-Yr Target (if PE normalizes)
(PE: 11â14)
$23.62
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 10.6%)
$56.55
(+139%)
Base:
(SPY PE: 11.4, Growth: 10.6%)
$32.07
(+35%)
Bear:
(PE: 9.7, Growth: 10.6%)
$27.26
(+15%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (18x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 17.66 | Current EPS (TTM): $1.33
Bull Case
$40.45
(+71%)
Analyst growth 56.5%, PE expands to 19.4
Base Case
$36.77
(+55%)
Market implied 56.5%, PE stable at 17.7
Bear Case
$15.97
(-33%)
Severe decline -20.0%, PE contracts to 15.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.4 to 13.7
Stabilization Target:
$28.52
(+20.4%)
PE Expansion Potential:
+20.4%
Share & Embed Analysis
Last updated: August 24, 2026 2:25 AM ET
Data refreshes hourly during market hours. Next update: 3:25 AM
Data refreshes hourly during market hours. Next update: 3:25 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OPCH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare CorporaâĻ |
STRONG BUY
22 analysts |
$282 | 37 SELL |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$451 | 44 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 42 HOLD |
|
ADUS
Addus HomeCare CorporatiâĻ |
STRONG BUY
11 analysts |
$135 | 54 HOLD |
